$HDSN
HUDSON TECHNOLOGIES INC /NY

2019 Q2 Form 10-Q Financial Statement

#000114420419023339 Filed on May 02, 2019

View on sec.gov

Income Statement

Concept 2019 Q2 2019 Q1 2018 Q4
Revenue $56.01M $34.66M $25.72M
YoY Change -3.15% -18.3% 4.5%
Cost Of Revenue $58.38M $27.68M $22.64M
YoY Change -30.43% -19.82% 4.86%
Gross Profit -$2.370M $6.985M $3.083M
YoY Change -90.91% -11.64% 1.85%
Gross Profit Margin -4.23% 20.15% 11.99%
Selling, General & Admin $6.850M $6.024M $6.230M
YoY Change -35.41% -25.42% -47.73%
% of Gross Profit 86.24% 202.08%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.840M $1.058M $1.780M
YoY Change 1.66% 4.55% 5.33%
% of Gross Profit 15.15% 57.74%
Operating Expenses $7.600M $6.745M $6.980M
YoY Change -33.02% -23.52% -44.88%
Operating Profit -$9.970M $240.0K -$3.897M
YoY Change -73.36% -126.26% -59.56%
Interest Expense -$4.270M $4.207M -$4.140M
YoY Change -227.62% 31.22% 38.46%
% of Operating Profit 1752.92%
Other Income/Expense, Net $510.0K -$4.139M
YoY Change -115.24% 39.93%
Pretax Income -$13.73M -$3.967M -$8.036M
YoY Change -66.33% -3.71% -36.2%
Income Tax $70.00K $72.00K $71.00K
% Of Pretax Income
Net Earnings -$13.80M -$4.039M -$8.107M
YoY Change -54.93% 32.17% 55.72%
Net Earnings / Revenue -24.64% -11.65% -31.52%
Basic Earnings Per Share -$0.09 -$0.19
Diluted Earnings Per Share -$323.9K -$0.09 -$0.19
COMMON SHARES
Basic Shares Outstanding 42.60M 42.60M 42.60M
Diluted Shares Outstanding 42.60M 42.60M

Balance Sheet

Concept 2019 Q2 2019 Q1 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.300M $1.200M $2.300M
YoY Change -43.48% 20.0% -54.0%
Cash & Equivalents $1.300M $1.170M $2.272M
Short-Term Investments
Other Short-Term Assets $6.800M $5.100M $5.300M
YoY Change 119.35% 30.77% -23.19%
Inventory $75.20M $99.77M $102.0M
Prepaid Expenses
Receivables $28.10M $20.10M $14.07M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $111.4M $126.2M $123.6M
YoY Change -31.94% -40.58% -40.84%
LONG-TERM ASSETS
Property, Plant & Equipment $32.00M $26.50M $27.40M
YoY Change 9.73% -10.63% -10.07%
Goodwill $47.80M $47.80M
YoY Change -3.36% -3.36%
Intangibles $28.73M $29.45M
YoY Change -9.3% -9.16%
Long-Term Investments
YoY Change
Other Assets $100.0K $91.00K $106.0K
YoY Change -43.18% -50.54% -42.39%
Total Long-Term Assets $107.8M $110.7M $104.8M
YoY Change -8.12% -0.26% -6.91%
TOTAL ASSETS
Total Short-Term Assets $111.4M $126.2M $123.6M
Total Long-Term Assets $107.8M $110.7M $104.8M
Total Assets $219.2M $236.9M $228.3M
YoY Change -22.0% -26.74% -28.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.700M $13.70M $8.700M
YoY Change -10.19% -53.08% -20.18%
Accrued Expenses $19.30M $20.40M $20.10M
YoY Change -17.17% 6.81% 9.84%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $31.00M $29.00M
YoY Change -100.0% -40.5% -55.49%
Long-Term Debt Due $132.7M $2.127M $2.672M
YoY Change 12538.1% 102.57% 154.48%
Total Short-Term Liabilities $161.6M $67.28M $60.41M
YoY Change 79.24% -33.69% -36.65%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $97.92M $98.27M
YoY Change -100.0% -3.05% -2.85%
Other Long-Term Liabilities $5.000M $5.600M
YoY Change
Total Long-Term Liabilities $5.000M $97.92M $98.27M
YoY Change -95.04% -3.05% -2.85%
TOTAL LIABILITIES
Total Short-Term Liabilities $161.6M $67.28M $60.41M
Total Long-Term Liabilities $5.000M $97.92M $98.27M
Total Liabilities $167.2M $171.3M $159.1M
YoY Change -12.46% -15.56% -19.63%
SHAREHOLDERS EQUITY
Retained Earnings -$50.97M -$46.93M
YoY Change -998.96% -637.78%
Common Stock $426.0K $426.0K
YoY Change 0.47%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $52.00M $65.55M $69.21M
YoY Change
Total Liabilities & Shareholders Equity $219.2M $236.9M $228.3M
YoY Change -22.0% -26.74% -28.96%

Cashflow Statement

Concept 2019 Q2 2019 Q1 2018 Q4
OPERATING ACTIVITIES
Net Income -$13.80M -$4.039M -$8.107M
YoY Change -54.93% 32.17% 55.72%
Depreciation, Depletion And Amortization $1.840M $1.058M $1.780M
YoY Change 1.66% 4.55% 5.33%
Cash From Operating Activities -$1.230M -$1.864M $1.020M
YoY Change 59.74% -119.61% -83.63%
INVESTING ACTIVITIES
Capital Expenditures -$110.0K $165.0K -$100.0K
YoY Change -80.7% -19.9% -37.5%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$110.0K -$165.0K -$100.0K
YoY Change -80.7% -19.9% -99.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net $1.073M
YoY Change 307.98%
Cash From Financing Activities 1.470M 927.0K -20.00K
YoY Change -45.56% -106.96% -100.01%
NET CHANGE
Cash From Operating Activities -1.230M -1.864M 1.020M
Cash From Investing Activities -110.0K -165.0K -100.0K
Cash From Financing Activities 1.470M 927.0K -20.00K
Net Change In Cash 130.0K -1.102M 900.0K
YoY Change -90.44% -72.61% -102.31%
FREE CASH FLOW
Cash From Operating Activities -$1.230M -$1.864M $1.020M
Capital Expenditures -$110.0K $165.0K -$100.0K
Free Cash Flow -$1.120M -$2.029M $1.120M
YoY Change 460.0% -121.82% -82.47%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q1 us-gaap Liabilities Current
LiabilitiesCurrent
67279000
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
98273000
CY2019Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
97918000
CY2018Q4 us-gaap Liabilities
Liabilities
159128000
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
29451000
CY2019Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
28730000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
106000
CY2019Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
91000
CY2018Q4 us-gaap Assets
Assets
228341000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27395000
CY2019Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
2127000
CY2018Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
29000000
CY2019Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26502000
CY2018Q4 us-gaap Goodwill
Goodwill
47803000
CY2019Q1 us-gaap Goodwill
Goodwill
47803000
CY2019Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
31000000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
60412000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2272000
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1170000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14065000
CY2019Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
20103000
CY2018Q4 us-gaap Inventory Net
InventoryNet
101962000
CY2019Q1 us-gaap Inventory Net
InventoryNet
99772000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5287000
CY2019Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5124000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
123586000
CY2019Q1 us-gaap Assets Current
AssetsCurrent
126169000
CY2019Q1 us-gaap Assets
Assets
236859000
CY2018Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
8671000
CY2019Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
13735000
CY2018Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
19023000
CY2019Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
19917000
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1046000
CY2019Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
500000
CY2018Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2672000
CY2019Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2019Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
426000
CY2019Q1 us-gaap Common Stock Value
CommonStockValue
426000
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
115719000
CY2019Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
116096000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-46932000
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-50971000
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
98273000
CY2018Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
129945000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
69213000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
65551000
CY2019Q1 hdsn Cost Of Sales Excluding Cost Of Net Realizable Value Adjustment
CostOfSalesExcludingCostOfNetRealizableValueAdjustment
27679000
CY2018Q1 hdsn Cost Of Sales Excluding Cost Of Net Realizable Value Adjustment
CostOfSalesExcludingCostOfNetRealizableValueAdjustment
34523000
CY2018Q1 hdsn Stock Issued During Period Value Stock Options And Warrants Exercised
StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised
17000
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42602431
CY2019Q1 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
7000
CY2019Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
3153000
CY2019Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
97918000
CY2018Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42403029
CY2019Q1 us-gaap Liabilities
Liabilities
171308000
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42602431
CY2018Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42403029
CY2019Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
131045000
CY2018Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
29000000
CY2018Q4 hdsn Longterm Debt Current Net Of Other Debt
LongtermDebtCurrentNetOfOtherDebt
2672000
CY2018Q4 us-gaap Debt Current
DebtCurrent
31672000
CY2018Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
101588000
CY2018Q4 hdsn Vehicle And Equipment Loans
VehicleAndEquipmentLoans
4000
CY2018Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
6000
CY2018Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
3325000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
228341000
CY2019Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
236859000
CY2019Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
515000
CY2018Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
443000
CY2019Q1 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
1991-01-11
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-4039000
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42602431
CY2018Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42403029
CY2019Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2018Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42602431
CY2018Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42403029
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4673897
CY2018Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2948848
CY2019Q1 us-gaap Revenues
Revenues
34664000
CY2018Q1 us-gaap Revenues
Revenues
42428000
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6024000
CY2018Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8077000
CY2019Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
721000
CY2018Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
742000
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
6745000
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
8819000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
240000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-914000
CY2019Q1 us-gaap Interest Expense
InterestExpense
4207000
CY2018Q1 us-gaap Interest Expense
InterestExpense
3206000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3967000
CY2018Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4120000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
72000
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1064000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-4039000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-3056000
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2019Q1 us-gaap Gross Profit
GrossProfit
6985000
CY2018Q1 us-gaap Gross Profit
GrossProfit
7905000
CY2019Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
37400000
CY2019Q1 us-gaap Inventory Net
InventoryNet
99772000
CY2018Q4 us-gaap Inventory Net
InventoryNet
101962000
CY2019Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
50638000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
50473000
CY2019Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
24136000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
23078000
CY2019Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26502000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-4039000
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
721000
CY2018Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
742000
CY2018Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
19160000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
165000
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
206000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5002000
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1170000
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
978000
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
3906000
CY2018Q1 us-gaap Interest Paid Net
InterestPaidNet
2930000
CY2019Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-165000
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-206000
CY2019Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1073000
CY2018Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
263000
CY2019Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1102000
CY2018Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-4024000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2272000
CY2018Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
17000
CY2019Q1 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
2000000
CY2018Q1 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-13075000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27395000
CY2019Q1 us-gaap Depreciation
Depreciation
1100000
CY2018Q1 us-gaap Depreciation
Depreciation
1000000
CY2018Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
34883000
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5432000
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
29451000
CY2019Q1 us-gaap Inventory Write Down
InventoryWriteDown
0
CY2018Q1 us-gaap Inventory Write Down
InventoryWriteDown
1080000
CY2019Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-243000
CY2018Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4000
CY2019Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
307000
CY2018Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
241000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
377000
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
27000
CY2019Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
72000
CY2018Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1064000
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5795000
CY2018Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12026000
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-5085000
CY2018Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-472000
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-43000
CY2018Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2911000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3425000
CY2019Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
34883000
CY2019Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6153000
CY2019Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
28730000
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
7000000
CY2019Q1 us-gaap Deferred Compensation Arrangement With Individual Common Stock Reserved For Future Issuance
DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance
2884509
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3600000
CY2019Q1 hdsn Sharebased Compensation Arrangement By Sharebased Payment Award Options Aggregate Intrinsic Value Nonvested
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAggregateIntrinsicValueNonvested
1400000
CY2019Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
31000000
CY2019Q1 hdsn Longterm Debt Current Net Of Other Debt
LongtermDebtCurrentNetOfOtherDebt
2127000
CY2019Q1 us-gaap Debt Current
DebtCurrent
33127000
CY2019Q1 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
101063000
CY2019Q1 hdsn Vehicle And Equipment Loans
VehicleAndEquipmentLoans
1000
CY2019Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42602431
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
26000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
377000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-4039000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
123453000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
120440000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
65551000
CY2019Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
8000
CY2018Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0
CY2019Q1 hdsn Lower Of Cost Or Net Realizable Value Adjustment
LowerOfCostOrNetRealizableValueAdjustment
-2895000
CY2018Q1 hdsn Lower Of Cost Or Net Realizable Value Adjustment
LowerOfCostOrNetRealizableValueAdjustment
0
CY2019Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
34664000
CY2018Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
42428000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
11300000
CY2019Q1 us-gaap Inventory Gross
InventoryGross
110263000
CY2018Q4 us-gaap Inventory Gross
InventoryGross
115348000
CY2019Q1 us-gaap Inventory Adjustments
InventoryAdjustments
10491000
CY2018Q4 us-gaap Inventory Adjustments
InventoryAdjustments
13386000
CY2019Q1 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
36100000
CY2018Q3 hdsn Earnings Before Interest Tax Depreciation And Amortization
EarningsBeforeInterestTaxDepreciationAndAmortization
9240000
CY2018Q4 hdsn Earnings Before Interest Tax Depreciation And Amortization
EarningsBeforeInterestTaxDepreciationAndAmortization
9428000
CY2019Q1 hdsn Earnings Before Interest Tax Depreciation And Amortization
EarningsBeforeInterestTaxDepreciationAndAmortization
9270000
CY2018Q4 us-gaap Deferred Tax Liabilities Deferred Expense Deferred Financing Costs
DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts
250000
CY2019Q1 us-gaap Capital Leased Assets Gross
CapitalLeasedAssetsGross
50000
CY2019Q1 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
28000
CY2019Q1 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
7000
CY2019Q1 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
0
CY2019Q1 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
0
CY2019Q1 hdsn Capital Lease Obligations Repayments Due
CapitalLeaseObligationsRepaymentsDue
35000
CY2019Q1 hdsn Capital Lease Obligations Repayments Interest Included In Payments
CapitalLeaseObligationsRepaymentsInterestIncludedInPayments
1000
CY2019Q1 us-gaap Capital Leases Future Minimum Payments Net Minimum Payments1
CapitalLeasesFutureMinimumPaymentsNetMinimumPayments1
34000
CY2019Q1 us-gaap Long Term Debt And Capital Lease Obligations Repayments Of Principal In Next Twelve Months
LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths
2127000
CY2019Q1 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo
2107000
CY2019Q1 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree
2102000
CY2019Q1 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Four
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour
2100000
CY2019Q1 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Five
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive
94762000
CY2019Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
103198000
CY2019Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2019Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
42602431
CY2019Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;">&#160;</div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Credit Risk</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of temporary cash investments and trade accounts receivable. The Company maintains its temporary cash investments in highly-rated financial institutions and, at times, the balances exceed FDIC insurance coverage. The Company&#8217;s trade accounts receivables are primarily due from companies throughout the United States. The Company reviews each customer&#8217;s credit history before extending credit.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company establishes an allowance for doubtful accounts based on factors associated with the credit risk of specific accounts, historical trends, and other information. The carrying value of the Company&#8217;s accounts receivable is reduced by the established allowance for doubtful accounts. The allowance for doubtful accounts includes any accounts receivable balances that are determined to be uncollectible, along with a general reserve for the remaining accounts receivable balances. The Company adjusts its reserves based on factors that affect the collectability of the accounts receivable balances.&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">For the three-month period ended March 31, 2019, there was one customer accounting for 15% of the Company&#8217;s revenues. At March 31, 2019 there was $3.0 million of accounts receivable from this customer.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">For the three-month period ended March 31, 2018, there was one customer accounting for 11% of the Company&#8217;s revenues. At March 31, 2018 there was $4.0 million of accounts receivable from this customer.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The loss of a principal customer or a decline in the economic prospects of and/or a reduction in purchases of the Company&#8217;s products or services by any such customer could have a material adverse effect on the Company&#8217;s operating results and financial position.</div><div style="background-color: initial; font-size: 10pt; letter-spacing: 0px; white-space: pre-line; top: 0px;;display:inline;">&#160;</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2018Q4 us-gaap Line Of Credit Facility Interest Rate Description
LineOfCreditFacilityInterestRateDescription
The Second Revolver Amendment also increases the applicable interest rate margin to 3% for Eurodollar Rate Loans (as defined in the PNC Facility) and 2% for Domestic Rate Loans (as defined in the PNC Facility) through September 30, 2019, with applicable margins thereafter of between 2.5% and 3% for Eurodollar Rate Loans and 1.5% and 2% for Domestic Rate Loans based on the applicable fixed charge coverage ratio.
CY2018Q4 us-gaap Debt Instrument Payment Terms
DebtInstrumentPaymentTerms
the Third Amendment requires a further repayment of principal on or before November 14, 2019 in an amount equal to (x) 100% of Excess Cash Flow (as defined in the Term Loan Facility) for the four fiscal quarter period ending September 30, 2019 if after giving effect to the payment thereof, the Borrowers have minimum aggregate Undrawn Availability (as defined in the Term Loan Facility) of at least $35,000,000, (y) 50% of Excess Cash Flow for the four fiscal quarter period ending September 30, 2019 if after giving effect to the payment thereof, the Borrowers have minimum aggregate Undrawn Availability of at least $15,000,000 but less than $35,000,000, and (z) 0% of Excess Cash Flow for the four fiscal quarter period ending September 30, 2019 if after giving effect to the payment thereof, the Borrowers have minimum aggregate Undrawn Availability less than $15,000,000, with any such payment subject to reduction by the amount of any voluntary prepayments made following the date of the Third Amendment.
CY2019Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;">&#160;</div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Estimates and Risks</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires the use of estimates and assumptions that affect the amounts reported in these financial statements and footnotes. The Company considers these accounting estimates to be critical in the preparation of the accompanying consolidated financial statements. The Company uses information available at the time the estimates are made. However, these estimates could change materially if different information or assumptions were used. Additionally, these estimates may not ultimately reflect the actual amounts of the final transactions that occur. The Company utilizes both internal and external sources to evaluate potential current and future liabilities for various commitments and contingencies. In the event that the assumptions or conditions change in the future, the estimates could differ from the original estimates.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.5in; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Several of the Company's accounting policies involve significant judgments, uncertainties and estimates. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions. To the extent that actual results differ from management's judgments and estimates, there could be a material adverse effect on the Company. On a continuous basis, the Company evaluates its estimates, including, but not limited to, those estimates related to its allowance for doubtful accounts, inventory reserves, and valuation allowance for the deferred tax assets relating to its NOLs and commitments and contingencies. With respect to accounts receivable, the Company estimates the necessary allowance for doubtful accounts based on both historical and anticipated trends of payment history and the ability of the customer to fulfill its obligations. For inventory, the Company evaluates both current and anticipated sales prices of its products to determine if a write down of inventory to net realizable value is necessary. In determining the Company&#8217;s valuation allowance for its deferred tax assets, the Company assesses its ability to generate taxable income in the future.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company participates in an industry that is highly regulated, and changes in the regulations affecting our business could affect our operating results. Currently the Company purchases virgin hydrochlorofluorocarbon (&#8220;HCFC&#8221;) and hydrofluorocarbon (&#8220;HFC&#8221;) refrigerants and reclaimable, primarily HCFC, HFC and chlorofluorocarbon (&#8220;CFC&#8221;), refrigerants from suppliers and its customers. Effective January 1, 1996, the Clean Air Act (the &#8220;Act&#8221;) prohibited the production of virgin CFC refrigerants and limited the production of virgin HCFC refrigerants. Effective January 2004, the Act further limited the production of virgin HCFC refrigerants and federal regulations were enacted which established production and consumption allowances for HCFC refrigerants which imposed limitations on the importation of certain virgin HCFC refrigerants. Under the Act, production of certain virgin HCFC refrigerants is scheduled to be phased out during the period 2010 through 2020, and production of all virgin HCFC refrigerants is scheduled to be phased out by 2030. In October 2014, the EPA published a final rule providing further reductions in the production and consumption allowances for virgin HCFC refrigerants for the years 2015 through 2019 (the &#8220;Final Rule&#8221;). In the Final Rule, the EPA established a linear draw down for the production or importation of virgin HCFC-22 that started at approximately 22 million pounds in 2015 and was reduced by approximately 4.5 million pounds each year ending at zero in 2020.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">To the extent that the Company is unable to source sufficient quantities of refrigerants or is unable to obtain refrigerants on commercially reasonable terms or experiences a decline in demand and/or price for refrigerants sold by the Company, the Company could realize reductions in revenue from refrigerant sales, which could have a material adverse effect on its operating results and its financial position.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company is subject to various legal proceedings. The Company assesses the merit and potential liability associated with each of these proceedings. In addition, the Company estimates potential liability, if any, related to these matters. To the extent that these estimates are not accurate, or circumstances change in the future, the Company could realize liabilities, which could have a material adverse effect on its operating results and its financial position.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2018Q4 us-gaap Line Of Credit Facility Commitment Fee Description
LineOfCreditFacilityCommitmentFeeDescription
The Third Amendment also amended the exit fee payable to the term loan lenders to five percent (5.00%) of the outstanding principal balance of the term loans on November 30, 2018 (the &#8220;Exit Fee&#8221;), which Exit Fee shall be payable in full in cash upon the earlier to occur of (x) repayment in full of the term loans, or (y) any acceleration of the term loans. The Exit Fee will be reduced by one-tenth of one percent (0.10%) for every $1,000,000 in voluntary prepayments made prior to January 1, 2020; provided, that, in no event shall the Exit Fee be reduced below three percent (3.00%) as a result of any such prepayments, (ii) payment of the Exit Fee shall be waived in the event that repayment in full of the term loans occurs prior to January 1, 2020, and (iii) the Exit Fee shall be reduced by an amount equal to fifty percent (50%) of the amount that would otherwise payable in the event that repayment in full occurs on or after January 1, 2020 but prior to March 31, 2020.
CY2018Q4 us-gaap Debt Instrument Fee Amount
DebtInstrumentFeeAmount
250000
CY2019Q1 hdsn Ratios Of Indebtedness To Net Capital Requirement
RatiosOfIndebtednessToNetCapitalRequirement
4.75 to 1.00
CY2019Q1 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P25Y
hdsn Ratios Of Indebtedness To Net Capital
RatiosOfIndebtednessToNetCapital
10.15:1.00
CY2019Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5596000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2039000
hdsn Ratios Of Indebtedness To Net Capital
RatiosOfIndebtednessToNetCapital
12.45:1.00
CY2018 hdsn Ratios Of Indebtedness To Net Capital
RatiosOfIndebtednessToNetCapital
12.75:1.00
CY2019Q1 hdsn Ratios Of Indebtedness To Net Capital
RatiosOfIndebtednessToNetCapital
12.95:1.00
hdsn Ratios Of Indebtedness To Net Capital
RatiosOfIndebtednessToNetCapital
8.25:1.00
hdsn Ratios Of Indebtedness To Net Capital
RatiosOfIndebtednessToNetCapital
6.40:1.00
CY2019 hdsn Ratios Of Indebtedness To Net Capital
RatiosOfIndebtednessToNetCapital
5:70:1.00
CY2020Q1 hdsn Ratios Of Indebtedness To Net Capital
RatiosOfIndebtednessToNetCapital
4:75:1.00
CY2018Q4 us-gaap Line Of Credit Facility Periodic Payment Principal
LineOfCreditFacilityPeriodicPaymentPrincipal
525000
CY2018Q4 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
28000000
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
3048602
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1.25
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P2Y6M3D
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
377000
CY2018Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
27000
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
258500
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
20000
CY2018Q1 hdsn Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable And Vested Intrinsic Value1
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableAndVestedIntrinsicValue1
13950
CY2018Q4 hdsn Sharebased Compensation Arrangement By Sharebased Payment Award Options Aggregate Intrinsic Value Nonvested
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAggregateIntrinsicValueNonvested
0
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2019Q1 hdsn Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable And Vested Intrinsic Value1
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableAndVestedIntrinsicValue1
0
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2211000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1590000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
701000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
520000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
3422000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
10483000
CY2019Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2900000
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
7583000
CY2019Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
20000
CY2018Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
0
CY2019Q1 hdsn Production And Importation Permission Description
ProductionAndImportationPermissionDescription
22 million pounds in 2015 and was reduced by approximately 4.5 million pounds each year ending at zero in 2020.
CY2019Q1 us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
(subject to annual limitations of 80% of tax earnings) and $5.4 million expire through 2023 (subject to annual limitations of approximately $1.3 million).
CY2019Q1 us-gaap Concentration Risk Customer
ConcentrationRiskCustomer
there was one customer accounting for 15% of the Company&#8217;s revenues.
CY2018Q1 us-gaap Concentration Risk Customer
ConcentrationRiskCustomer
there was one customer accounting for 11% of the Company&#8217;s revenues.
CY2019Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019Q1 dei Document Period End Date
DocumentPeriodEndDate
2019-03-31
CY2019Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
9503000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
927000
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-13321000
CY2019Q1 dei Document Type
DocumentType
10-Q
CY2019Q1 dei Amendment Flag
AmendmentFlag
false
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
7583000
CY2019Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0874
CY2019Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y7M6D
CY2019Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P11Y
CY2019Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
700000
CY2019Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
700000
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7564000
CY2018Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0
CY2019Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5596000
CY2018Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42602431
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
42602431
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1864000
CY2019Q1 dei Entity Registrant Name
EntityRegistrantName
HUDSON TECHNOLOGIES INC /NY
CY2019Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000925528
CY2019Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2019Q1 dei Trading Symbol
TradingSymbol
HDSN
CY2019Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
42602431
CY2019Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1058000
CY2018Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1012000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
69213000
CY2019Q1 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
13300000
CY2019Q1 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
0
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
2952000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
2055000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1619000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
684000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
3422000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
11230000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
498000

Files In Submission

Name View Source Status
0001144204-19-023339-index-headers.html Edgar Link pending
0001144204-19-023339-index.html Edgar Link pending
0001144204-19-023339.txt Edgar Link pending
0001144204-19-023339-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hdsn-20190331.xml Edgar Link completed
hdsn-20190331.xsd Edgar Link pending
hdsn-20190331_cal.xml Edgar Link unprocessable
hdsn-20190331_def.xml Edgar Link unprocessable
hdsn-20190331_lab.xml Edgar Link unprocessable
hdsn-20190331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tv519514_10q.htm Edgar Link pending
tv519514_ex10-1.htm Edgar Link pending
tv519514_ex10-2.htm Edgar Link pending
tv519514_ex31-1.htm Edgar Link pending
tv519514_ex31-2.htm Edgar Link pending
tv519514_ex32-1.htm Edgar Link pending
tv519514_ex32-2.htm Edgar Link pending